Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NASDAQ:GCVRZ)

0.258
Delayed Data
As of Aug 26
 -0.007 / -2.64%
Today’s Change
0.06
Today|||52-Week Range
0.28
+129.33%
Year-to-Date
Sanofi's Risk Increases on Acquisition Miss
Aug 28 / GuruFocus News - Paid Partner Content
Pfizer-Medivation Close to Signing $14B Acquisition Deal? (revised)
Aug 22 / Zacks.com - Paid Partner Content
These Next-Generation Cholesterol Drugs Could Raise U.S. Healthcare Costs by $119 Bil...
Aug 27 / MotleyFool.com - Paid Partner Content
Medivation Scores Premium in Sale to Pfizer
Aug 22 / TheStreet.com - Paid Partner Content
Pharmaceuticals are the New Bonds
Aug 26 / GuruFocus News - Paid Partner Content
3 Stocks We Wouldn't Touch With a 10-Foot Pole
Aug 22 / MotleyFool.com - Paid Partner Content
Game On for Pfizer With $14 Billion Medivation Buyout (or, Why Pfizer's Buyout of Med...
Aug 26 / MotleyFool.com - Paid Partner Content
ETFs in Focus on Pfizer's Medivation Acquisition
Aug 22 / Zacks.com - Paid Partner Content
Tone-Deaf Mylan Provides Election-Year Fodder
Aug 25 / MotleyFool.com - Paid Partner Content
Medivation's Shares Soar on Confirmation of a Pfizer Buyout
Aug 22 / MotleyFool.com - Paid Partner Content
Cramer: It's a Presidential Campaign, So Let the Corporate Bashing Begin
Aug 24 / TheStreet.com - Paid Partner Content
Biotechs Rally on Pfizer/Medivation Deal
Aug 22 / TheStreet.com - Paid Partner Content
Mylan Falls After Being Called Out on Price Increases -- Should You Worry?
Aug 24 / TheStreet.com - Paid Partner Content
Sanofi Diabetes Combination Drug FDA Action Date Extended
Aug 22 / Zacks.com - Paid Partner Content
Dear Pfizer, Stop Overpaying for Acquisitions!
Aug 24 / MotleyFool.com - Paid Partner Content
Pfizer to Buy Medivation for $14B, Boost Cancer Franchise
Aug 22 / Zacks.com - Paid Partner Content
Mylan (MYL) Draws Flak for Over Pricing EpiPen, Stock Down
Aug 24 / Zacks.com - Paid Partner Content
Bret Jensen Reporting for Duty
Aug 22 / TheStreet.com - Paid Partner Content
Regeneron Stock Up on BARDA Deal for MERS Antibodies
Aug 23 / Zacks.com - Paid Partner Content
5 Things You Must Know Before the Market Opens Monday
Aug 22 / TheStreet.com - Paid Partner Content
What Pfizer Gets in Its $14 Billion Medivation Deal
Aug 23 / MotleyFool.com - Paid Partner Content
Pfizer-Medivation Close to Signing $14B Acquisition Deal?
Aug 22 / Zacks.com - Paid Partner Content
Pfizer to Buy Medivation for $14B, Boost Cancer Franchise (revised)
Aug 23 / Zacks.com - Paid Partner Content
3 Reasons Medivation Is the Juiciest Target in Biotech
Aug 21 / MotleyFool.com - Paid Partner Content
Pfizer (PFE) Bought Medivation (MDVN), but is it a Good Deal?
Aug 22 / Zacks.com - Paid Partner Content
Why Portola Pharmaceuticals Inc Is Plunging Today
Aug 18 / MotleyFool.com - Paid Partner Content